Elevated Microsomal Antibodies (MAB): Causes and Clinical Significance

Microsomal antibodies (anti-LKM1, anti-LC1) target liver endoplasmic reticulum enzymes (cytochrome P450). Elevation suggests autoimmune or drug-induced liver injury.

Major Etiologies

1. Autoimmune Hepatitis (AIH) Type 2

  • Anti-LKM1 (CYP2D6) – classic; pediatric/young female predominance.
  • Anti-LC1 (formiminotransferase cyclodeaminase) – often co-occurs.
  • High IgG, interface hepatitis on biopsy. Responds to steroids/azathioprine.

2. Drug-Induced Liver Injury (DILI)

  • Drugs metabolized by CYP2D6/2C9/3A4 can form hapten-protein complexes → autoantibodies.
  • Common culprits: nitrofurantoin, minocycline, hydralazine, isoniazid, methyldopa, statins, anticonvulsants (phenytoin, carbamazepine), checkpoint inhibitors.
  • Resolution after withdrawal (months).

3. Chronic Hepatitis C (Historical)

Anti-LKM1 seen in 10–20% of HCV (genotype 1); less relevant in DAA era.

4. Other Autoimmune/Overlap Syndromes

  • Primary biliary cholangitis (PBC), primary sclerosing cholangitis (PSC), overlap syndromes.

5. Genetic/Metabolic

  • Wilson disease, alpha-1 antitrypsin deficiency can have autoantibodies.

Diagnostic Approach

  1. Confirm elevation (titer, specificity).
  2. Exclude viral hepatitis (A/B/C/E), alcohol, NAFLD, medications.
  3. Liver biopsy if AIH suspected (interface hepatitis, plasma cells).
  4. Simplified AIH scoring system (IAIHG).

Management

  • AIH: Prednisone ± azathioprine → remission, then taper to maintenance.
  • DILI: Stop offending drug; steroids if severe (Hy's law criteria).
  • Monitor LFTs, IgG, antibodies q3–6mo.

Isolated low-titer microsomal antibodies may be incidental. Correlate with clinical picture.

Genetic Disorders - Related Articles